Bioxcel alert: bragar eagel & squire, p.c. is investigating bioxcel therapeutics, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york--(business wire)-- #a--bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against bioxcel therapeutics, inc. (nasdaq: btai) on behalf of long-term stockholders following a class action complaint that was filed against bioxcel on july 7, 2023 with a class period from december 15, 2021 to june 28, 2023. our investigation concerns whether the board of directors of bioxcel have breached their fiduciary duties to the company. o.
BTAI Ratings Summary
BTAI Quant Ranking